Skip to menu Skip to content Skip to footer
Associate Professor John O'Sullivan
Associate Professor

John O'Sullivan

Email: 

Overview

Background

After completing neurology training at the Royal Brisbane & Women’s Hospital(RBWH) in 1995, A/Prof O’Sullivan completed Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre, Melbourne then the National Hospital for Neurology and Neurosurgery, and Middlesex Hospital in London, UK. He was awarded a doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He returned to the RBWH in 2001 and set up the Movement Disorders Clinical Service which he directs including botulinum toxin and later Friedreich's ataxia clinics, and co-ordinating the Huntington's disease multidisciplinary clinic. Through these clinics he has established collaborations with local, interstate and international researchers in the fields of Parkinson's disease, and other movement disorders and neurodegenerative diseases. He is currently Associate Professor of Medicine at UQ Centre for Clinical Research, currently co-director of the Neurodegenertion Clinical Research Group. A/Prof O'Sullivan past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ), having previously served as Chair of the MDSANZ Clinical Trials and Research Group. He has been is on the Council of the Australian and New Zealand Association of Neurolgists (ANZAN) and previously chaired the ANZAN Scientific Program Committee.

Availability

Associate Professor John O'Sullivan is:
Available for supervision
Media expert

Research interests

  • Non-motor features of Parkinson's disease

    This research involves studies into depression, anxiety and cognitive function in Parkinson's disease in collaboration with Dr Nadeeka Dissanayaka, Dr Robert Adam, Prof Gerard Byrne, Dr Nancy Pachana & Dr Rodney Marsh

  • Novel compounds and clinical trials in neurodegenerative diseases

    Research involves novel compounds and repurposed drugs for treatment and disease-modification in Parkinson's, Huntington's disease, Friedreich's Ataxia, Progressive Supranuclear Palsy and motor neurone diseases in collaboration with Dr Richard Gordon, A/Prof Trent Woodruff, A/Prof Rob Henderson, Prof Pam McCombe, Dr Robert Adam and Wesley Medical Research.

  • Exercise in Parkinson's disease

    In collaboration with Prof Sandy Brauer, Dr Robyn Lamont, and Wesley Medical Research, studies exploring maintenance of exercise, gait and boxing in Parkinson's disease.

  • Sleep in neurodegenerative diseases

    These studies in collaboration with Dr Simon Smith, Dr Jane Nikles and Wesley Medical Research explore novel aspects involving sleep in Parkinson's, Huntington's and motor neurone diseases and Friedreich's ataxia

Research impacts

A/Prof O’Sullivan’s novel investigator-initiated clinical trial in Parkinson’s disease (PD) (Mov Dis 2007; 22:1543-9) is cited in the American Academy of Neurology Practice Parameters and MDS Evidence Based Medicine Review of Management of Non-motor symptoms in PD. The initial description of syndrome of Dopamine Dysregulation in PD (JNNP 2000; 68:423-428) complicating dopamine replacement therapy in some patients with Parkinson’s disease has led to widespread recognition of the syndrome, and this paper has had more than 400 citations. The Movement Disorders Society revision of the Unified Parkinson’s Disease Rating Scale (MDS–UPDRS) includes a section to address features of the dopamine dysregulation syndrome as a result of this. This research has also contributed to debate about addiction in general (Addiction. 2012;107(2):253).

Works

Search Professor John O'Sullivan’s works on UQ eSpace

241 works between 1988 and 2025

161 - 180 of 241 works

2010

Journal Article

Current concepts in the management of Parkinson disease

Hayes, Michael W., Fung, Victor S., Kimber, Thomas E. and O'Sullivan, John D. (2010). Current concepts in the management of Parkinson disease. Medical Journal of Australia, 192 (3), 144-149. doi: 10.5694/j.1326-5377.2010.tb03453.x

Current concepts in the management of Parkinson disease

2010

Conference Publication

Repetitive Transcranial Magnetic Stimulation (rTMS) and sham modulation of language function in non-fluent aphasia 2 months post stimulation

Barwood, Caroline, Murdoch, Bruce, Whelan, Brooke-Mai, Lloyd, David, Riek, Stephan and O'Sullivan, John (2010). Repetitive Transcranial Magnetic Stimulation (rTMS) and sham modulation of language function in non-fluent aphasia 2 months post stimulation. AoA2010: 48th Academy of Aphasia Proceedings, Athens, Greece, 23-26 October, 2010. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.sbspro.2010.08.117

Repetitive Transcranial Magnetic Stimulation (rTMS) and sham modulation of language function in non-fluent aphasia 2 months post stimulation

2010

Conference Publication

Risk factors for depression in Parkinson’s disease

Dissanayaka, N. N., O’Sullivan, J. D., Silburn, P. A. and Mellick, G. D. (2010). Risk factors for depression in Parkinson’s disease. 7th International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease and Related Disorders, Barcelona, Spain, 9-12 December 2010.

Risk factors for depression in Parkinson’s disease

2010

Conference Publication

Factors associated with freezing of gait in Parkinson’s disease

Dissanayaka, N., O’Sullivan, J., Silburn, P. and Mellick, G. (2010). Factors associated with freezing of gait in Parkinson’s disease. 19th Annual RBWH Health Care Symposium, Brisbane, Australia, 11-15 October 2010.

Factors associated with freezing of gait in Parkinson’s disease

2010

Conference Publication

Immune response in acute ischaemic stroke

Badve, Monica S., Yan, J., Hull, R., Henderson, Robert, O’Sullivan, John D., Read, Stephen J., Wong, Andrew A. and McCombe, Pamela (2010). Immune response in acute ischaemic stroke. ANZAN Annual Scientific Meeting 2010, -, 2010. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2010.07.064

Immune response in acute ischaemic stroke

2009

Journal Article

Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease

Dissanayaka, Nadeeka N. W., Sellebach, Annabelle N., Matheson, Sally, Marsh, Rodney, O'Sullivan, John D., Silburn, Peter A., Byrne, Gerard J. and Mellick, George D. (2009). Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease. Movement Disorders, 24 (16), 2435-2438. doi: 10.1002/mds.22819

Validity of a self-rated method to identify a lifetime history of depression in Parkinson's disease

2009

Journal Article

Do Polymorphisms in the Familial Parkinsonism Genes Contribute to Risk for Sporadic Parkinson's Disease?

Sutherland, GT, Halliday, GM, Silburn, PA, Mastaglia, FL, Rowe, DB, Boyle, RS, O'Sullivan, JD, Ly, T, Wilton, SD and Mellick, GD (2009). Do Polymorphisms in the Familial Parkinsonism Genes Contribute to Risk for Sporadic Parkinson's Disease?. MOVEMENT DISORDERS, 24 (6), 833-838. doi: 10.1002/mds.22214

Do Polymorphisms in the Familial Parkinsonism Genes Contribute to Risk for Sporadic Parkinson's Disease?

2009

Conference Publication

The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease

O’Maley, Karen A., O’Sullivan, John D., Wollin, Judy and Barras, Michael (2009). The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease. Australian and New Zealand Association of Neurologists (ANZAN) 2008 Annual Scientific Meeting, Australia, 2008. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jocn.2008.07.043

The impact of an individualised medication information session on medication knowledge and quality of life of people with parkinson’s disease

2009

Journal Article

Haplotype Analysis of the PARK 11 Gene, GIGYF2, in Sporadic Parkinson's Disease

Sutherland, Greg T., Siebert, Gerhard A., Newman, Jeremy R.B., Silburn, Peter A., Boyle, Richard S., O'Sullivan, John D. and Mellick, George D. (2009). Haplotype Analysis of the PARK 11 Gene, GIGYF2, in Sporadic Parkinson's Disease. Movement Disorders, 24 (3), 449-452. doi: 10.1002/mds.22427

Haplotype Analysis of the PARK 11 Gene, GIGYF2, in Sporadic Parkinson's Disease

2009

Journal Article

Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease

Dissanayaka, Nadeeka N. W., Silburn, Peter A., O'Sullivan, John D. and Mellick, George D. (2009). Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease. Movement Disorders, 24 (1), 111-115. doi: 10.1002/mds.22134

Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease

2009

Conference Publication

Risk factors for depression in Parkinson’s disease

Dissanayaka, N. N., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2009). Risk factors for depression in Parkinson’s disease. 1st Joint Conference of the APS Psychology and Ageing Interest Group, and the Royal Australian and New Zealand College of Psychiatrists Faculty of Psychiatry of Old Age, Gold Coast, Australia, 12-14 November 2009.

Risk factors for depression in Parkinson’s disease

2009

Conference Publication

Risk factors for depression in Parkinson’s disease

Dissanayaka, N., Sellbach, A., Matheson, S., O'Sullivan, J., Silburn, P. A., Marsh, R., Byrne, G. and Mellick, G. (2009). Risk factors for depression in Parkinson’s disease. 18th Annual RBWH Health Care Symposium, Brisbane, Australia, October 2009.

Risk factors for depression in Parkinson’s disease

2009

Conference Publication

Assessing depression in Parkinson’s disease

Dissanayaka, N. N. W., Sellbach, A., Matheson, S., Marsh, R., Silburn, P. A., O'Sullivan, J. D., Byrne, G. J. and Mellick, G. D. (2009). Assessing depression in Parkinson’s disease. 5th National Conference on Depression in Elderly., Sydney, Australia, 2009.

Assessing depression in Parkinson’s disease

2009

Journal Article

Immune activation in the peripheral blood of patients with acute ischemic stroke

Yan, Jun, Greer, Judith M., Etherington, Kellie, Cadigan, Greg P., Cavanagh, Helen, Henderson, Robert D., O'Sullivan, John D., Pandian, Jeyaraj D., Read, Stephen J. and McCombe, Pamela A. (2009). Immune activation in the peripheral blood of patients with acute ischemic stroke. Journal of Neuroimmunology, 206 (1-2), 112-117. doi: 10.1016/j.jneuroim.2008.11.001

Immune activation in the peripheral blood of patients with acute ischemic stroke

2009

Conference Publication

What contributes to depression in Parkinson’s disease?

Dissanayaka, N. N. W., Silburn, P. A., O’Sullivan, J. D. and Mellick, J. D. (2009). What contributes to depression in Parkinson’s disease?. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 26 May 2009.

What contributes to depression in Parkinson’s disease?

2008

Journal Article

Natural history of blood glucose within the first 48 hours after ischemic stroke

Wong, A. A., Schluter, P. J., Henderson, R. D., O'Sullivan, J. D. and Read, S. J. (2008). Natural history of blood glucose within the first 48 hours after ischemic stroke. Neurology, 70 (13), 1036-1041. doi: 10.1212/01.wnl.0000306635.08410.68

Natural history of blood glucose within the first 48 hours after ischemic stroke

2008

Conference Publication

Is depression in Parkinson’s disease ‘organic’ or ‘reactive’

Dissanayaka, N., Silburn, P., O’Sullivan, J. and Mellick, G. (2008). Is depression in Parkinson’s disease ‘organic’ or ‘reactive’. Australian Society for Medical Research Queensland Postgraduate Student Conference, Brisbane, Australia, 29 May 2008.

Is depression in Parkinson’s disease ‘organic’ or ‘reactive’

2008

Conference Publication

Risk factors for depression in Parkinson’s disease

Dissanayaka, N., O’Sullivan, J., Silburn, P. and Mellick, G. (2008). Risk factors for depression in Parkinson’s disease. 6th International Congress on Mental Dysfunctions and Other Non-motor Features in Parkinson’s Disease, Dresden, Germany, 16-19 October 2008.

Risk factors for depression in Parkinson’s disease

2007

Journal Article

The time course and determinants of blood pressure within the first 48 h after ischemic stroke

Wong, Andrew A., Davis, James P., Schluter, Philip J., Henderson, Robert D., O’Sullivan, John D. and Read, Stephen J. (2007). The time course and determinants of blood pressure within the first 48 h after ischemic stroke. Cerebrovascular Diseases, 24 (5), 426-433. doi: 10.1159/000108432

The time course and determinants of blood pressure within the first 48 h after ischemic stroke

2007

Journal Article

Unusual triggers for stroke

Pandian, Jeyaraj Durai, Perel, Robert, Henderson, Robert D., O'Sullivan, John D. and Read, Stephen (2007). Unusual triggers for stroke. Journal of Clinical Neuroscience, 14 (8), 786-787. doi: 10.1016/j.jocn.2006.05.012

Unusual triggers for stroke

Funding

Current funding

  • 2024 - 2028
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD)
    Western Sydney Local Health District
    Open grant
  • 2023 - 2026
    A randomised controlled trial of N-Acetyl Cysteine for premanifest Huntington gene expansion carriers (NAC-preHD)
    Huntington's Australia Research Grant
    Open grant
  • 2023 - 2026
    Mining the gut microbiome to develop new treatments and biomarkers for Parkinson's disease
    Wesley Medical Research Ltd
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2022 - 2025
    Mining the inflammasome-gut microbiome axis to uncover new biomarkers and therapeutic targets for Parkinson's disease
    Research Donation Generic
    Open grant
  • 2022 - 2025
    Validating Magnetic Resonance diagnosis in Parkinson's Disease
    Research Donation Generic
    Open grant
  • 2022 - 2026
    Gilchrist Family Parkinson's Research Program
    Research Donation Generic
    Open grant
  • 2020 - 2025
    Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP) (MRFF RCRDUN Neurological Disorders Grant administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2024 - 2025
    Evaluation of noval disease-modifying therapeutics for Parkinson's disease (The Michael J. Fox Foundation for Parkinson's Research Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2022 - 2024
    Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease
    The Michael J Fox Foundation Therapeutic Pipeline Program
    Open grant
  • 2021 - 2023
    Comparative and Cross Validation of alpha- Synuclein Seeding Assays in Peripheral Biomatrices skin, submandibular gland, CSF, Saliva and Tear Fluids
    University of Georgia
    Open grant
  • 2021 - 2023
    Validating the functional role of the pathogenic microbiome metabolite Trimethylamine (TMA) at the gut-brain axis in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease (TRIP study)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A randomised placebo-controlled crossover trial of micronised resveratrol as a treatment for Friedreich ataxia
    Murdoch Childrens Research Institute
    Open grant
  • 2019 - 2022
    Pharmacological targeting of inflammasome activation mechanisms in synuclein models of Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2018 - 2019
    Targeting peripheral inflammatory pathology in Parkinson's disease using repurposed drugs
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2023
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD) (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2018
    Sleep measurements in Friedreich's ataxia, Huntington's disease patients and healthy volunteers
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2019
    Virtual reality innovation to treat anxiety in patients with cognitive impairment and Parkinson's Disease
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2019
    Therapeutic switching of a licensed oncology drug to target neuropathology in Parkinson's disease
    The Cure Parkinson's Trust
    Open grant
  • 2017 - 2019
    Defining inflammatory biomarkers in motor neuron disease patients to assist in clinical trial efficiency of the C5aR antagonist PMX205
    Wesley Medical Research Ltd
    Open grant
  • 2017 - 2023
    The Queensland Drug Repurposing Initiative
    Queensland Government Advance Queensland Innovation Partnerships
    Open grant
  • 2016 - 2018
    Pharmacological Targeting of Proinflammatory Kinase Signalling in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2016 - 2017
    Cognitive behaviour therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2015 - 2017
    Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Mindfulness therapy for depression, anxiety, motor and cognitive dysfunction in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2016
    Developing a non-invasive composite measure to enhance accuracy of identifying anxiety in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013 - 2014
    Characterising anxiety in Parkinson's disease: A psycholinguistic and psychophysiology study comparing to anxious older adults
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2012 - 2013
    Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2011 - 2013
    Therapeutic Targeting of Complement C5a Receptors in Huntington's Disease
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor John O'Sullivan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Master Philosophy

    Digital symptom tracking - using digital tools for measuring and tracking motor, cognitive, and speech changes

    Associate Advisor

  • Doctor Philosophy

    The evolution of cognitive deficits in Lewy body disorders and related degenerative diseases.

    Associate Advisor

    Other advisors: Professor Peter Nestor

Completed supervision

Media

Enquiries

Contact Associate Professor John O'Sullivan directly for media enquiries about:

  • Botulinum toxin
  • Dystonia
  • Huntington's disease
  • Movement disorders
  • Parkinson's disease

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au